Dimensional Fund Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Buy |
563,365
+167,897
| +42% | +$7.33M | 0.01% | 1871 |
|
|
2025
Q1 | $10.8M | Sell |
395,468
-38,287
| -9% | -$1.05M | ﹤0.01% | 2218 |
|
|
2024
Q4 | $17.4M | Sell |
433,755
-38,871
| -8% | -$1.56M | ﹤0.01% | 2051 |
|
|
2024
Q3 | $22.4M | Buy |
472,626
+70,241
| +17% | +$3.33M | 0.01% | 1953 |
|
|
2024
Q2 | $12M | Buy |
402,385
+53,176
| +15% | +$1.59M | ﹤0.01% | 2182 |
|
|
2024
Q1 | $14M | Sell |
349,209
-184,514
| -35% | -$7.42M | ﹤0.01% | 2165 |
|
|
2023
Q4 | $13.6M | Sell |
533,723
-121,504
| -19% | -$3.09M | ﹤0.01% | 2179 |
|
|
2023
Q3 | $9.11M | Sell |
655,227
-185,711
| -22% | -$2.58M | ﹤0.01% | 2312 |
|
|
2023
Q2 | $19.3M | Buy |
840,938
+100,947
| +14% | +$2.32M | 0.01% | 1949 |
|
|
2023
Q1 | $21.9M | Buy |
739,991
+426,831
| +136% | +$12.6M | 0.01% | 1854 |
|
|
2022
Q4 | $7.82K | Buy |
313,160
+100,795
| +47% | +$2.52K | ﹤0.01% | 2311 |
|
|
2022
Q3 | $4.62M | Buy |
212,365
+25,084
| +13% | +$546K | ﹤0.01% | 2452 |
|
|
2022
Q2 | $3.69M | Sell |
187,281
-50,450
| -21% | -$993K | ﹤0.01% | 2544 |
|
|
2022
Q1 | $10.1M | Buy |
237,731
+172,839
| +266% | +$7.31M | ﹤0.01% | 2298 |
|
|
2021
Q4 | $4.12M | Buy |
+64,892
| New | +$4.12M | ﹤0.01% | 2626 |
|